Anticancer Drug Delivery with Transferrin Targeted Polymeric Chitosan Vesicles
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 21 (1) , 101-107
- https://doi.org/10.1023/b:pham.0000012156.65125.01
Abstract
Purpose. The study reports the initial biological evaluation of targeted polymeric glycol chitosan vesicles as carrier systems for doxorubicin (Dox). Methods. Transferrin (Tf) was covalently bound to...Keywords
This publication has 25 references indexed in Scilit:
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Expression and localization of GLUT1 and GLUT12 in prostate carcinomaCancer, 2003
- Antitumour activity and adverse reactions of combined treatment with chitosan and doxorubicin in tumour-bearing miceJournal of Pharmacy and Pharmacology, 2001
- Openings between Defective Endothelial Cells Explain Tumor Vessel LeakinessThe American Journal of Pathology, 2000
- Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1.1999
- Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing miceInternational Journal of Pharmaceutics, 1999
- Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.1999
- HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell lineJournal of Controlled Release, 1998
- Polymeric Chitosan-based Vesicles for Drug DeliveryJournal of Pharmacy and Pharmacology, 1998
- EFFECTS OF THE PH-DEPENDENCE OF 3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYL-TETRAZOLIUM BROMIDE-FORMAZAN ABSORPTION ON CHEMOSENSITIVITY DETERMINED BY A NOVEL TETRAZOLIUM-BASED ASSAY1989